Remove Doctors Remove Drug Development Remove Molecular Biology
article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

Transposon technologies are gaining traction due to their accuracy in integrating the gene of interest into the host genome, making them an important tool for accelerating large molecule drug development. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies. Front Genet.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference

Alta Sciences

One thing is for sure—regardless of how the field evolves around regulation requirements, Altasciences has the experience and range of capabilities to take on your gene therapy drug development programs. Connect with Dr.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. Bioinformatics is all about bringing together different areas of knowledge.

article thumbnail

Alzheimer’s disease: driving advancements with precision medicine

Drug Target Review

The Role of Biomarkers in Alzheimer’s Disease Drug Development. Progress in molecular biology and translational science. A how-to guide for a precision medicine approach to the diagnosis and treatment of alzheimer’s disease. link] Cummings J. Adv Exp Med Biol. 2019;1118:29-61. doi: 10.1007/978-3-030-05542-4_2.

Disease 59
article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Link to her profile: [link]. About Longwood University.

article thumbnail

Scaling Phage Therapy

Codon

Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria? ” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, UTIs, diabetic foot ulcers).

Therapies 118